Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer

Heppner BI, Untch M, Denkert C, Pfitzner BM, Lederer B, Schmidt W, Eidtmann H, Fasching P, Tesch H, Solbach C, Rezai M, Zahm DM, Holms F, Glados M, Krabisch P, Heck E, Ober A, Lorenz P, Diebold K, Habeck J, Loibl S (2016)

Publication Type: Conference contribution

Publication year: 2016

Journal

Oncology Research and Treatment Karger Publishers

Book Volume: 39

Pages Range: 5-5

Authors with CRIS profile

Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

Klinikum Chemnitz DE Germany (DE) SRH Wald-Klinikum Gera DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) St. Vincenz Krankenhaus Limburg DE Germany (DE) GBG Forschungs GmbH (German Breast Group) DE Germany (DE) HELIOS Kliniken DE Germany (DE) Johanna-Etienne-Krankenhaus DE Germany (DE) St. Barbara-Klinik Hamm DE Germany (DE) Luisenkrankenhaus Düsseldorf DE Germany (DE) Centrum für Hämatologie und Onkologie Bethanien DE Germany (DE) Universitätsklinikum Schleswig-Holstein (UKSH) DE Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE)

How to cite

APA:

Heppner, B.I., Untch, M., Denkert, C., Pfitzner, B.M., Lederer, B., Schmidt, W.,... Loibl, S. (2016). Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer. (pp. 5-5).

MLA:

Heppner, B. Ingold, et al. "Tumor-infiltrating lymphocytes and response prediction to neoadjuvant chemotherapy in HER2-positive breast cancer." 2016. 5-5.

BibTeX: Download